Conference Programme

New Horizons for Bio Innovation

6 July 2023

Our Programme

Keynote Presentations & Panel Discussions

Enjoy a day of Keynote Presentations and Panel discussions, plus the Exhibition Area and Innovation Support Hub and many networking opportunities.



Jon Green, One Nucleus

Keynote Presentation: Creating an Innovation Space

Tim Schoen, BioMed Realty

A keynote presentation looking at the key ingredients in an ecosystem needed to achieve new horizons for bio innovation with a focus on the Cambridge UK Life Science ecosystem.

Keynote Presentation: Why Does No One Discuss Supply Chain?

Paul Grindall

Paul Grindall, Biocair International

New Horizons in Genetic Screening

Moderator: Priya Kalia, SciTribe

Panellists: Debora Lucarelli, Enhanc3D Genomics, Kate Harvey, Genomics England, Kerry Thompson, BC Platforms, Edyta Wojtowicz, Earlham Institute

As clinical genomics becomes more advanced, where have the biggest impacts been seen, is this tackling unmet need and are we ready for the revolution?

Coffee Break

New Horizons in Paediatric Medicines

Moderator: Paul Branthwaite, tranScrip

Panellists: Anna Moore, NIHR BioResource, Becky Bishop, PHTA Ltd, Beatrice Panico, Scendea, Becky Birch, The Brain Tumour Charity

What is helping to encourage more investment into paediatric medicines and what are the tools that will help us to serve this population better?

New Horizons in Precision Oncology

Moderator: Sue Charles, Charles Consultants

Panellists: John Lyons, Astex, Robin Carr, Myricx, Neil Jones, Cancer Research Horizons, Daniel Marshall, MSD, Glen Clack, tranScrip 

What are the barriers being encountered and what is missing to ensure translation of the science into therapeutic interventions to offer hope to patients to live healthier and longer lives.


New Horizons in AI-Based Prediction & Prevention

Moderator: Parminder Lally, Appleyard Lees

Panellists: Sven Sewitz, Eagle Genomics, Zizi Imatorbhebhe, Bios Health Group, Krzysztof Potempa, BRAINCURES, Stephen Baker, AstraZeneca, Jürgen Harter, CCDC

AI can be used as an intervention at different stages of disease management, from diagnosis to treatment decisions. But what is the potential of AI to prevent some of the most burdensome life-style related chronic diseases such as heart disease, cancer and diabetes?  

Longevity Depends on Understanding the Biology

Moderator: Adrian Toutoungi, Taylor Wessing

Panellists: Janette Thomas, Five Alarm Bio Ltd, Panteli Theocharous, PPD, Daniel Ives, Shift Bioscience, Delphine Larrieu, University of Cambridge, Rebecca Canter, Eli Lilly 

With advances in technology such as the use of effective biomarkers and stem cells to replace lost neurons, where is research currently and where should we be hoping to see the most progress?

Coffee Break

BioNewsRound Award Winner Announced

When Do Good Neighbours Become Good Business Partners?

Moderator: Mike Ward, Clarivate

Panellists: James Fry, Mills & Reeve, Claire Thompson, Agility Life Sciences, Mike Anstey, Cambridge Innovation Capital, Laragh Jeanroy, RSM, Laura Lane, Eli Lilly 

A panel reflecting on the dynamic of the wider ecosystem, and how the interplay between locations could unlock the next wave of innovation and drive the scale of innovation.

Closing Remarks

Tony Jones, One Nucleus

Drinks Reception


Programme is subject to change